COUR PHARMACEUTICALS DEV COMPANY INC has a total of 34 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, environmental technology and biotechnology are SCICLONE PHARMACEUTICALS, BILLION KING INT LTD and MERRION RES III LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Israel | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Australia | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Peptides | |
#5 | Unspecified technologies | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Getts Daniel R | 28 |
#2 | Pearson Ryan | 9 |
#3 | Puisis John | 7 |
#4 | Herrmann James | 6 |
#5 | Fokta Frank | 3 |
#6 | Terry Rachael | 3 |
#7 | King Nicholas | 3 |
#8 | Getts Daniel | 2 |
#9 | Daniel R Getts | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020028544A1 | Immune modifying particles for the treatment of cancer | |
CN111867565A | Treatment of celiac disease using tolerant particles | |
EP3416624A1 | Process for the preparation of tolerizing immune-modulating particles | |
KR20180105243A | TIMPS encapsulating Japanese cedar pollen epitope | |
WO2017120222A1 | Particles encapsulating fusion proteins containing linked epitopes | |
EP3393514A1 | Covalent polymer-antigen conjugated particles | |
WO2017075053A1 | Immune-modifying particles for the treatment of malaria |